Cortically Based Brain Tumors in Children: A Decision-Tree Approach in the Radiology Reading Room

References

1. 1.↵
   1. Ostrom QT,
   2. Price M,
   3. Neff C, et al

   . CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol 2023;25:iv1–99 doi:10.1093/neuonc/noad149 pmid:37793125

   CrossRefPubMed
2. 2.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
3. 3.↵
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
4. 4.↵
   1. Jessa S,
   2. Blanchet-Cohen A,
   3. Krug B, et al

   . Stalled developmental programs at the root of pediatric brain tumors. Nat Genet 2019;51:1702–13 doi:10.1038/s41588-019-0531-7 pmid:31768071

   CrossRefPubMed
5. 5.↵
   1. Buccoliero AM,
   2. Giunti L,
   3. Moscardi S, et al

   . Pediatric high grade glioma classification criteria and molecular features of a case series. Genes (Basel) 2022;13:624 doi:10.3390/genes13040624 pmid:35456430

   CrossRefPubMed
6. 6.↵
   1. Kalelioglu T,
   2. Emerson D,
   3. Luk A, et al

   . Imaging features of diffuse hemispheric glioma, H3 G34-mutant: report of 4 cases. J Neuroradiol 2023;50:309–14 doi:10.1016/j.neurad.2022.12.001 pmid:36493960

   CrossRefPubMed
7. 7.↵
   1. Kurokawa R,
   2. Baba A,
   3. Emile P, et al

   . Neuroimaging features of angiocentric glioma: a case series and systematic review. J Neuroimaging 2022;32:389–99 doi:10.1111/jon.12983 pmid:35201652

   CrossRefPubMed
8. 8.↵
   1. Vuong HG,
   2. Le HT,
   3. Dunn IF

   . The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas. Cancer 2022;128:1907–12 doi:10.1002/cncr.34156 pmid:35195909

   CrossRefPubMed
9. 9.↵
   1. Onishi S,
   2. Amatya VJ,
   3. Karlowee V, et al

   . Radiological and immunostaining characteristics of H3.3 G34R-mutant glioma: a report of 3 cases and review of the literature. Pediatr Neurosurg 2020;55:319–25 doi:10.1159/000511672 pmid:33227796

   CrossRefPubMed
10. 10.↵
    1. Picart T,
    2. Barritault M,
    3. Poncet D, et al

    . Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neurooncol Adv 2021;3:vdab061 doi:10.1093/noajnl/vdab061 pmid:34056608

    CrossRefPubMed
11. 11.↵
    1. Korshunov A,
    2. Capper D,
    3. Reuss D, et al

    . Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 2016;131:137–46 doi:10.1007/s00401-015-1493-1

    CrossRefPubMed
12. 12.↵
    1. Puntonet J,
    2. Dangouloff-Ros V,
    3. Saffroy R, et al

    . Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation. J Neuroradiol 2018;45:316–22 doi:10.1016/j.neurad.2018.02.006 pmid:29505840

    CrossRefPubMed
13. 13.↵
    1. Wang L,
    2. Shao L,
    3. Li H, et al

    . Histone H3.3 G34-mutant diffuse gliomas in adults. Am J Surg Pathol 2022;46:249–57 doi:10.1097/PAS.0000000000001781 pmid:34352809

    CrossRefPubMed
14. 14.↵
    1. Lasocki A,
    2. Abdalla G,
    3. Chow G, et al

    . Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review. Cancer Imaging 2022;22:63 doi:10.1186/s40644-022-00500-3

    CrossRefPubMed
15. 15.↵
    1. Johnson DR,
    2. Giannini C,
    3. Vaubel RA, et al

    . A radiologist’s guide to the 2021 WHO Central Nervous System Tumor Classification: part I-Key concepts and the spectrum of diffuse gliomas. Radiology 2022;304:494–508 doi:10.1148/radiol.213063

    CrossRefPubMed
16. 16.↵
    1. Lavrador JP,
    2. Reisz Z,
    3. Sibtain N, et al

    . H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series. Acta Neurochir (Wien) 2023;165:1615–33 doi:10.1007/s00701-023-05545-2 pmid:36929449

    CrossRefPubMed
17. 17.↵
    1. Nafe R,
    2. Porto L,
    3. Samp PF, et al

    . Adult-type and pediatric-type diffuse gliomas: what the neuroradiologist should know. Clin Neuroradiol 2023;33:611–24 doi:10.1007/s00062-023-01277-z pmid:36941392

    CrossRefPubMed
18. 18.↵
    1. Tauziède-Espariat A,
    2. Debily MA,
    3. Castel D, et al

    . The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts. Acta Neuropathol Commun 2020;8:104 doi:10.1186/s40478-020-00974-x

    CrossRefPubMed
19. 19.↵
    1. Gonçalves FG,
    2. Alves C,
    3. Vossough A

    . Updates in pediatric malignant gliomas. Top Magn Reson Imaging 2020;29:83–94 doi:10.1097/RMR.0000000000000235 pmid:32271285

    CrossRefPubMed
20. 20.↵
    1. Gonçalves FG,
    2. Viaene AN,
    3. Vossough A

    . Advanced magnetic resonance imaging in pediatric glioblastomas. Front Neurol 2021;12:733323 doi:10.3389/fneur.2021.733323 pmid:34858308

    CrossRefPubMed
21. 21.↵
    1. DeSisto J,
    2. Lucas JT, Jr.,
    3. Xu K, et al

    . Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat Commun 2021;12:5531 doi:10.1038/s41467-021-25709-x pmid:34545084

    CrossRefPubMed
22. 22.↵
    1. Korshunov A,
    2. Schrimpf D,
    3. Ryzhova M, et al

    . H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol 2017;134:507–16 doi:10.1007/s00401-017-1710-1

    CrossRefPubMed
23. 23.↵
    1. Guerreiro Stucklin AS,
    2. Ryall S,
    3. Fukuoka K, et al

    . Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun 2019;10:4343 doi:10.1038/s41467-019-12187-5 pmid:31554817

    CrossRefPubMed
24. 24.↵
    1. Tauziède-Espariat A,
    2. Beccaria K,
    3. Dangouloff-Ros V, et al

    . A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma. Brain Pathol 2023;33:e13182

    CrossRefPubMed
25. 25.↵
    1. Olsen TK,
    2. Panagopoulos I,
    3. Meling TR, et al

    . Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity? Neuro Oncol 2015;17:1365–73 doi:10.1093/neuonc/nov039 pmid:25795305

    CrossRefPubMed
26. 26.↵
    1. Louis DN,
    2. Ohgaki H,
    3. Wiestler OD, et al

    . The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 2007;114:97–109 doi:10.1007/s00401-007-0243-4 pmid:17618441

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Ampie L,
    2. Choy W,
    3. DiDomenico JD, et al

    . Clinical attributes and surgical outcomes of angiocentric gliomas. J Clin Neurosci 2016;28:117–22 doi:10.1016/j.jocn.2015.11.015

    CrossRefPubMed
28. 28.↵
    1. Amemiya S,
    2. Shibahara J,
    3. Aoki S, et al

    . Recently established entities of central nervous system tumors: review of radiological findings. J Comput Assist Tomogr 2008;32:279–85 doi:10.1097/RCT.0b013e31814ce981 pmid:18379318

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Aguilar HN,
    2. Hung RW,
    3. Mehta V, et al

    . Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature. J Radiology Case Rep 2012;6:1–10 doi:10.3941/jrcr.v6i10.1134 pmid:23378871

    CrossRefPubMed
30. 30.↵
    1. Miyata H,
    2. Ryufuku M,
    3. Kubota Y, et al

    . Adult-onset angiocentric glioma of epithelioid cell-predominant type of the mesial temporal lobe suggestive of a rare but distinct clinicopathological subset within a spectrum of angiocentric cortical ependymal tumors. Neuropathology 2012;32:479–91 doi:10.1111/j.1440-1789.2011.01278.x

    CrossRefPubMed
31. 31.↵
    1. Ni HC,
    2. Chen SY,
    3. Chen L, et al

    . Angiocentric glioma: a report of nine new cases, including four with atypical histological features. Neuropathol Appl Neurobiol 2015;41:333–46 doi:10.1111/nan.12158 pmid:24861831

    CrossRefPubMed
32. 32.↵
    1. Wagner MW,
    2. Nobre L,
    3. Namdar K, et al

    . T2-FLAIR mismatch sign in pediatric low-grade glioma. AJNR Am J Neuroradiol 2023;44:841–45 doi:10.3174/ajnr.A7916

    Abstract/FREE Full Text
33. 33.↵
    1. Chen G,
    2. Wang L,
    3. Wu J, et al

    . Intractable epilepsy due to angiocentric glioma: a case report and minireview. Exp Ther Med 2014;7:61–65 doi:10.3892/etm.2013.1402

    CrossRefPubMed
34. 34.↵
    1. Chiang J,
    2. Harreld JH,
    3. Tinkle CL, et al

    . A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta Neuropathol 2019;138:1091–92 doi:10.1007/s00401-019-02081-1 pmid:31595312

    CrossRefPubMed
35. 35.↵
    1. Wefers AK,
    2. Stichel D,
    3. Schrimpf D, et al

    . Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol 2020;139:193–209 doi:10.1007/s00401-019-02078-w pmid:31563982

    CrossRefPubMed
36. 36.↵
    1. Purkait S,
    2. Mahajan S,
    3. Sharma MC, et al

    . Pediatric-type diffuse low grade gliomas: histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification. Indian J Pathol Microbiol 2022;65:S42–49

    CrossRefPubMed
37. 37.↵
    1. Huse JT,
    2. Snuderl M,
    3. Jones DT, et al

    . Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 2017;133:417–29 doi:10.1007/s00401-016-1639-9 pmid:27812792

    CrossRefPubMed
38. 38.↵
    1. AlRayahi J,
    2. Zapotocky M,
    3. Ramaswamy V, et al

    . Pediatric brain tumor genetics: what radiologists need to know. Radiographics 2018;38:2102–22 doi:10.1148/rg.2018180109

    CrossRefPubMed
39. 39.↵
    1. Chen Y,
    2. Tian T,
    3. Guo X, et al

    . Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations. BMC Neurol 2020;20:123 doi:10.1186/s12883-020-01679-3

    CrossRefPubMed
40. 40.↵
    1. Barretto BB,
    2. Mani J,
    3. Venkatraman S, et al

    . Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): a newly described entity of special radiological significance. Indian J Radiology Imaging 2023;33:567–70 doi:10.1055/s-0043-1771362 pmid:37811183

    CrossRefPubMed
41. 41.↵
    1. Ida CM,
    2. Johnson DR,
    3. Nair AA, et al

    . Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): molecular profiling confirms frequent MAPK pathway activation. J Neuropathol Exp Neurol 2021;80:821–29 doi:10.1093/jnen/nlab075

    CrossRefPubMed
42. 42.↵
    1. Bag AK,
    2. Chiang J,
    3. Patay Z

    . Radiohistogenomics of pediatric low-grade neuroepithelial tumors. Neuroradiology 2021;63:1185–213 doi:10.1007/s00234-021-02691-1 pmid:33779771

    CrossRefPubMed
43. 43.↵
    1. Isler C,
    2. Erturk Cetin O,
    3. Ugurlar D, et al

    . Dysembryoplastic neuroepithelial tumours: clinical, radiological, pathological features and outcome. Br J Neurosurg 2018;32:436–41 doi:10.1080/02688697.2018.1476671 pmid:29792345

    CrossRefPubMed
44. 44.↵
    1. Mano Y,
    2. Kumabe T,
    3. Shibahara I, et al

    . Dynamic changes in magnetic resonance imaging appearance of dysembryoplastic neuroepithelial tumor with or without malignant transformation. J Neurosurg Pediatr 2013;11:518–25 doi:10.3171/2013.1.PEDS11449

    CrossRefPubMed
45. 45.↵
    1. Adachi Y,
    2. Yagishita A

    . Gangliogliomas: characteristic imaging findings and role in the temporal lobe epilepsy. Neuroradiology 2008;50:829–34 doi:10.1007/s00234-008-0410-x

    CrossRefPubMed
46. 46.↵
    1. Chen J,
    2. Qi X,
    3. Zhang M, et al

    . Review on neuroimaging in pediatric-type diffuse low-grade gliomas. Front Pediatr 2023;11:1149646 doi:10.3389/fped.2023.1149646

    CrossRefPubMed
47. 47.↵
    1. Qaddoumi I,
    2. Orisme W,
    3. Wen J, et al

    . Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 2016;131:833–45 doi:10.1007/s00401-016-1539-z pmid:26810070

    CrossRefPubMed
48. 48.↵
    1. Banerjee A,
    2. Jakacki RI,
    3. Onar-Thomas A, et al

    . A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol 2017;19:1135–44 doi:10.1093/neuonc/now282

    CrossRefPubMed
49. 49.↵
    1. Perreault S,
    2. Larouche V,
    3. Tabori U, et al

    . A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01. BMC Cancer 2019;19:1250 doi:10.1186/s12885-019-6442-2 pmid:31881853

    CrossRefPubMed
50. 50.↵
    1. Hammas N,
    2. Senhaji N,
    3. Alaoui Lamrani MY, et al

    . Astroblastoma - a rare and challenging tumor: a case report and review of the literature. J Med Case Rep 2018;12:102 doi:10.1186/s13256-018-1623-1 pmid:29678196

    CrossRefPubMed
51. 51.↵
    1. Sprenger F,
    2. da Silva EB, Jr.,
    3. Cavalcanti MS, et al

    . Radiology-pathology and surgical correlation in astroblastoma. AJNR Am J Neuroradiol 2023;44:390–95 doi:10.3174/ajnr.A7824 pmid:36958802

    Abstract/FREE Full Text
52. 52.↵
    1. Port JD,
    2. Brat DJ,
    3. Burger PC, et al

    . Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. AJNR Am J Neuroradiol 2002;23:243–47 pmid:11847049

    PubMedWeb of Science
53. 53.↵
    1. Lehman NL,
    2. Usubalieva A,
    3. Lin T, et al

    . Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun 2019;7:42 doi:10.1186/s40478-019-0689-3 pmid:30876455

    CrossRefPubMed
54. 54.↵
    1. Sugita Y,
    2. Terasaki M,
    3. Shigemori M, et al

    . Astroblastoma with unusual signet-ring-like cell components: a case report and literature review. Neuropathology 2002;22:200–205 doi:10.1046/j.1440-1789.2002.00435.x pmid:12416560

    CrossRefPubMed
55. 55.↵
    1. Thiessen B,
    2. Finlay J,
    3. Kulkarni R, et al

    . Astroblastoma: does histology predict biologic behavior? J Neurooncol 1998;40:59–65 doi:10.1023/a:1006025000409 pmid:9874187

    CrossRefPubMed
56. 56.↵
    1. Detti B,
    2. Scoccianti S,
    3. Maragna V, et al

    . Pleomorphic xanthoastrocytoma: a single institution retrospective analysis and a review of the literature. Radiology Med 2022;127:1134–41 doi:10.1007/s11547-022-01531-3

    CrossRef
57. 57.↵
    1. Moore W,
    2. Mathis D,
    3. Gargan L, et al

    . Pleomorphic xanthoastrocytoma of childhood: MR imaging and diffusion MR imaging features. AJNR Am J Neuroradiol 2014;35:2192–96 doi:10.3174/ajnr.A4011 pmid:24994821

    Abstract/FREE Full Text
58. 58.↵
    1. Perkins SM,
    2. Mitra N,
    3. Fei W, et al

    . Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis. J Neurooncol 2012;110:99–104 doi:10.1007/s11060-012-0939-8 pmid:22843450

    CrossRefPubMed
59. 59.↵
    1. Giannini C,
    2. Scheithauer BW,
    3. Burger PC, et al

    . Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999;85:2033–45 pmid:10223246

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Fukuoka K,
    2. Mamatjan Y,
    3. Tatevossian R, et al

    . Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas. Neuro Oncol 2020;22:1474–83 doi:10.1093/neuonc/noaa077 pmid:32242226

    CrossRefPubMed
61. 61.↵
    1. Phillips JJ,
    2. Gong H,
    3. Chen K, et al

    . The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathol 2019;29:85–96 doi:10.1111/bpa.12639 pmid:30051528

    CrossRefPubMed
62. 62.↵
    1. Ebrahimi A,
    2. Korshunov A,
    3. Reifenberger G, et al

    . Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. Acta Neuropathol Commun 2022;10:5 doi:10.1186/s40478-021-01308-1 pmid:35012690

    CrossRefPubMed
63. 63.↵
    1. Tekkök IH,
    2. Sav A

    . Anaplastic pleomorphic xanthoastrocytomas. Review of the literature with reference to malignancy potential. Pediatr Neurosurg 2004;40:171–81 doi:10.1159/000081935 pmid:15608490

    CrossRefPubMed
64. 64.↵
    1. Nunes RH,
    2. Hsu CC,
    3. da Rocha AJ, et al

    . Multinodular and vacuolating neuronal tumor of the cerebrum: a new “leave me alone” lesion with a characteristic imaging pattern. AJNR Am J Neuroradiol 2017;38:1899–904 doi:10.3174/ajnr.A5281

    Abstract/FREE Full Text
65. 65.↵
    1. Alsufayan R,
    2. Alcaide-Leon P,
    3. de Tilly LN, et al

    . Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor. Neuroradiology 2017;59:873–83 doi:10.1007/s00234-017-1884-1 pmid:28752311

    CrossRefPubMed
66. 66.↵
    1. Pekmezci M,
    2. Stevers M,
    3. Phillips JJ, et al

    . Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol 2018;135:485–88 doi:10.1007/s00401-018-1820-4

    CrossRefPubMed
67. 67.↵
    1. Choi E,
    2. Kim SI,
    3. Won JK, et al

    . Clinicopathological and molecular analysis of multinodular and vacuolating neuronal tumors of the cerebrum. Hum Pathol 2019;86:203–12 doi:10.1016/j.humpath.2018.11.028

    CrossRefPubMed
68. 68.↵
    1. Park YW,
    2. Vollmuth P,
    3. Foltyn-Dumitru M, et al

    . The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: part 3-summary of imaging findings on glioneuronal and neuronal tumors. J Magn Reson Imaging 2023;58:1680–702 doi:10.1002/jmri.29016 pmid:37715567

    CrossRefPubMed
69. 69.↵
    1. Lecler A,
    2. Chauvet D,
    3. Biassette HA, et al

    . Multiparametric imaging improves confidence in the diagnosis of multinodular and vacuolating neuronal tumor of the cerebrum. AJNR Am J Neuroradiol 2018;39:E32–33 doi:10.3174/ajnr.A5425 pmid:29051207

    FREE Full Text
70. 70.↵
    1. Deng MY,
    2. Sill M,
    3. Sturm D, et al

    . Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol 2020;46:422–30 doi:10.1111/nan.12590 pmid:31867747

    CrossRefPubMed
71. 71.↵
    1. Pickles JC,
    2. Mankad K,
    3. Aizpurua M, et al

    . A case series of diffuse glioneuronal tumours with oligodendroglioma-like features and nuclear clusters (DGONC). Neuropathology Appl Neurobiol 2021;47:464–67 doi:10.1111/nan.12680

    CrossRefPubMed
72. 72.↵
    1. Benesch M,
    2. Perwein T,
    3. Apfaltrer G, et al

    . MR imaging and clinical characteristics of diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters. AJNR Am J Neuroradiol 2022;43:1523–29 doi:10.3174/ajnr.A7647 pmid:36137663

    Abstract/FREE Full Text
73. 73.↵
    1. Schindler G,
    2. Capper D,
    3. Meyer J, et al

    . Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011;121:397–405 doi:10.1007/s00401-011-0802-6 pmid:21274720

    CrossRefPubMedWeb of Science
74. 74.↵
    1. Ramaglia A,
    2. Tortora D,
    3. Mankad K, et al

    . Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type. Neuroradiology 2020;62:71–80 doi:10.1007/s00234-019-02304-y pmid:31667545

    CrossRefPubMed
75. 75.↵
    1. VandenBerg SR,
    2. May EE,
    3. Rubinstein LJ, et al

    . Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (“desmoplastic infantile gangliogliomas”). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg 1987;66:58–71 doi:10.3171/jns.1987.66.1.0058 pmid:3097276

    CrossRefPubMedWeb of Science
76. 76.↵
    1. Koelsche C,
    2. Sahm F,
    3. Paulus W, et al

    . BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma. Neuropathol Appl Neurobiol 2014;40:337–44 doi:10.1111/nan.12072 pmid:23822828

    CrossRefPubMed
77. 77.↵
    1. Daumas-Duport C,
    2. Varlet P,
    3. Bacha S, et al

    . Dysembryoplastic neuroepithelial tumors: nonspecific histological forms – a study of 40 cases. J Neurooncol 1999;41:267–80 doi:10.1023/a:1006193018140 pmid:10359147

    CrossRefPubMed
78. 78.↵
    1. Daumas-Duport C

    . Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993;3:283–95 doi:10.1111/j.1750-3639.1993.tb00755.x pmid:8293188

    CrossRefPubMedWeb of Science
79. 79.↵
    1. Campos AR,
    2. Clusmann H,
    3. von Lehe M, et al

    . Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology 2009;51:433–43 doi:10.1007/s00234-009-0511-1 pmid:19242688

    CrossRefPubMedWeb of Science
80. 80.↵
    1. Thom M,
    2. Gomez-Anson B,
    3. Revesz T, et al

    . Spontaneous intralesional haemorrhage in dysembryoplastic neuroepithelial tumours: a series of five cases. J Neurol Neurosurg Psychiatry 1999;67:97–101 doi:10.1136/jnnp.67.1.97

    Abstract/FREE Full Text
81. 81.↵
    1. Shin JH,
    2. Lee HK,
    3. Khang SK, et al

    . Neuronal tumors of the central nervous system: radiologic findings and pathologic correlation. Radiographics 2002;22:1177–89 doi:10.1148/radiographics.22.5.g02se051177 pmid:12235346

    CrossRefPubMedWeb of Science
82. 82.↵
    1. Bulakbasi N,
    2. Kocaoglu M,
    3. Sanal TH, et al

    . Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics. Neuroradiology 2007;49:805–12 doi:10.1007/s00234-007-0263-8

    CrossRefPubMed
83. 83.↵
    1. Sturm D,
    2. Orr BA,
    3. Toprak UH, et al

    . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–72 doi:10.1016/j.cell.2016.01.015 pmid:26919435

    CrossRefPubMed
84. 84.↵
    1. Shimazaki K,
    2. Kurokawa R,
    3. Franson A, et al

    . Neuroimaging features of FOXR2-activated CNS neuroblastoma: a case series and systematic review. J Neuroimaging 2023;33:359–67 doi:10.1111/jon.13095 pmid:36806312

    CrossRefPubMed
85. 85.↵
    1. Kalu IC,
    2. Kao CM,
    3. Fritz SA

    . Management and prevention of Staphylococcus aureus infections in children. Infect Dis Clin North Am 2022;36:73–100 doi:10.1016/j.idc.2021.11.006

    CrossRefPubMed
86. 86.↵
    1. Wang R,
    2. Guan W,
    3. Qiao M, et al

    . CNS tumor with BCOR internal tandem duplication: clinicopathologic, molecular characteristics and prognosis factors. Pathol Res Pract 2022;236:153995 doi:10.1016/j.prp.2022.153995 pmid:35809497

    CrossRefPubMed
87. 87.↵
    1. Cardoen L,
    2. Tauziède-Espariat A,
    3. Dangouloff-Ros V, et al

    . Imaging features with histopathologic correlation of CNS high-grade neuroepithelial tumors with a BCOR internal tandem duplication. AJNR Am J Neuroradiol 2022;43:151–56 doi:10.3174/ajnr.A7367

    Abstract/FREE Full Text
88. 88.↵
    1. Lambo S,
    2. von Hoff K,
    3. Korshunov A, et al

    . ETMR: a tumor entity in its infancy. Acta Neuropathol 2020;140:249–66 doi:10.1007/s00401-020-02182-2

    CrossRefPubMed
89. 89.↵
    1. Meliti A,
    2. Gasim W,
    3. Al-Maghrabi H, et al

    . Embryonal tumor with multilayered rosettes; rare pediatric CNS tumor. A case report and review of literature. Int J Pediatr Adolesc Med 2022;9:174–78 doi:10.1016/j.ijpam.2021.11.002

    CrossRefPubMed
90. 90.↵
    1. Calandrelli R,
    2. Massimi L,
    3. Pilato F, et al

    . Atypical teratoid rhabdoid tumor: proposal of a diagnostic pathway based on clinical features and neuroimaging findings. Diagnostics (Basel) 2023;13:doi:10.3390/diagnostics13030475 pmid:36766580

    CrossRefPubMed
91. 91.↵
    1. Bethel JA,
    2. James KM,
    3. Tavakoli SG, et al

    . Supratentorial ependymoma, zinc finger translocation-associated fusion positive, with extensive synaptophysin immunoreactivity arising from malignant transformation of clear cell ependymoma: a case report. Surg Neurol Int 2022;13:168 doi:10.25259/SNI_984_2021 pmid:35509570

    CrossRefPubMed
92. 92.↵
    1. Tauziède-Espariat A,
    2. Siegfried A,
    3. Nicaise Y, et al

    ; RENOCLIP-LOC, the BIOMECA (Biomarkers for Ependymomas in Children, Adolescents) consortium. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions. Acta Neuropathol Commun 2021;9:135 doi:10.1186/s40478-021-01238-y pmid:34389065

    CrossRefPubMed
93. 93.↵
    1. Pajtler KW,
    2. Witt H,
    3. Sill M, et al

    . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27:728–43 doi:10.1016/j.ccell.2015.04.002

    CrossRefPubMed
94. 94.↵
    1. Mangalore S,
    2. Aryan S,
    3. Prasad C, et al

    . Imaging characteristics of supratentorial ependymomas: study on a large single institutional cohort with histopathological correlation. Asian J Neurosurg 2015;10:276–81 doi:10.4103/1793-5482.162702 pmid:26425155

    CrossRefPubMed
95. 95.↵
    1. Mu W,
    2. Dahmoush H

    . Classification and neuroimaging of ependymal tumors. Front Pediatr 2023;11:1181211 doi:10.3389/fped.2023.1181211

    CrossRefPubMed
96. 96.↵
    1. Andreiuolo F,
    2. Varlet P,
    3. Tauziède-Espariat A, et al

    . Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Brain Pathol 2019;29:205–16 doi:10.1111/bpa.12659 pmid:30246434

    CrossRefPubMed